16 Hrs
Source:
التيار الوطني الحر
Source: التيار الوطني الحر
16 Hrsالتيار الوطني الحر
Source: التيار الوطني الحر
16 HrsReady to play
Ready to play
A study involving two groups, each comprising 36,460 adults aged 60 and older and followed for up to seven years, found that recipients of the Shingrix vaccine were 10% less likely to develop ischemic heart disease, 12% less likely to develop heart failure, and 9% less likely to experience an event included in a composite outcome that included ischemic stroke, compared with recipients of the older Zostavax vaccine. The researchers suggest that Shingrix’s adjuvant may help reduce inflammation, but the study does not establish a causal link and is not sufficient to recommend the vaccine for preventing heart disease; its primary purpose remains preventing shingles.
Notice: This Is an AI-Generated Summary
Comments (0)